Summary: “Will old-school profit-centered tactics bring down decades of dogged work by activists, scientists, and reformers to have these drugs reassessed for their virtues?” In the cover story of The Nation’s special issue Psychedelics Inc., Zoe Cormier cautions against the looming impacts of “the strange new world of ‘psychedelic capitalism'” as profit-driven companies prepare to commercialize psychedelics. Cormier traverses the vast psychedelic space—past, present, and future—and seeks perspective from psychedelic experts, including MAPS Founder and Executive Director Rick Doblin, Ph.D. Consider the effects of profit-centered business models on psychedelic research, treatment access, and patient outcomes.
The Nation: The Brave New World of Legalized Psychedelics Is Already Here
